New guidance from the U.S. Food and Drug Administration (FDA) says most clinical research on foods and nutrients—other than that designed solely to assess safety or tolerance—can be undertaken only after an Investigational New Drug (IND) application is filed. This fundamental change in FDA’s regulation of food research has broad implications for food technologists, clinical nutrition investigators, and the food industry.

In September FDA issued Guidance for Clinical Investigato…

Premium Content
You've reached your monthly limit of free articles.
Access Food Technology
Log in Subscribe